ADVFN ADVFN

Hot Features

Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd (RDY)

13,29
0,14
(1,06%)
Fermé 20 Juin 10:00PM
12,862
-0,428
(-3,22%)
Après les heures de négociation: 11:02PM

Dr Reddys Laboratories Ltd (RDY) Action

Votre Hub pour des idées et discussions en direct en temps réel

Premium

Statistiques et détails clés

Dernier
12,862
( -2,19% )
Prix Achat
-
Prix Vente
-
Volume échangé
2 007 838
13,205 Fourchette du Jour 13,36
12,185 Plage de 52 semaines 15,71
Cap du marché
Clôture Veille
13,15
Ouverture
13,30
Dernière Transaction
303604
@
13.29
Dernière heure de transaction
Volume financier
US$ 26 600 547
VWAP
13,2484
Volume moyen (3 m)
US$ 85 643
Actions en circulation
832 691 395
Rendement du Dividende (LTM)
8 (0,63%)
Ratio Cours sur Bénéfices
24,88
Bénéfice par action (BPA)
51,42
Chiffre d'affairess (LTM)
335,93B
Bénéfice net (LTM)
42,85B

À propos de Dr Reddys Laboratories Ltd

Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its G... Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations, as well as engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids with the customer requirements. Its Others segment engages in developing therapies in the fields of oncology and inflammation; and research, development, and commercialization of differentiated formulations. The company offers its products for various therapeutic categories, including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology, vaccines, vitamins and minerals, and pain management. Dr. Reddy's Laboratories Limited was incorporated in 1984 and is headquartered in Hyderabad, India. Show more

Secteur
Healthcare
Industrie
Pharmaceuticals
Site Web
Siège social
Hyderabad, India
Fondé
1984
Dr Reddys Laboratories Ltd est coté dans le secteur Healthcare de la New York Stock Exchange avec le ticker RDY. Le dernier cours de clôture d'Dr Reddys Laboratories était de US$13,15. Au cours de la dernière année, les actions de Dr Reddys Laboratories ont été négociées dans une fourchette de prix de US$ 12,185 à US$ 15,71.

Dr Reddys Laboratories compte actuellement 832 691 395 actions en circulation. La capitalisation boursière d'Dr Reddys Laboratories est de US$10,71 milliard. Dr Reddys Laboratories a un ratio cours/bénéfice (ratio PE) de 24.88.

RDY Dernières nouvelles

PériodeVariationVariation %Ouver.HautBasMoyenne Vol. Quot.VWAP
1-0.498-3.7275449101813.3613.4712.862157222813.25767165CS
4-0.708-5.2173913043513.5713.8612.862150593313.34570661CS
12-0.958-6.9319826338613.8214.212.185233934613.32886754CS
26-1.158-8.2596291012814.0214.812.185209044413.62470948CS
52-2.418-15.824607329815.2815.7112.185162327813.86186899CS
156-47.358-78.641647293360.2284.4612.185102247120.01597545CS
260-59.058-82.11624026771.9284.4612.18568581924.0000672CS

RDY - Frequently Asked Questions (FAQ)

What is the current Dr Reddys Laboratories Ltd share price?
The current share price of Dr Reddys Laboratories Ltd is US$ 12,862
How many Dr Reddys Laboratories Ltd shares are in issue?
Dr Reddys Laboratories Ltd has 832 691 395 shares in issue
What is the market cap of Dr Reddys Laboratories Ltd?
The market capitalisation of Dr Reddys Laboratories Ltd is USD 10,71B
What is the 1 year trading range for Dr Reddys Laboratories Ltd share price?
Dr Reddys Laboratories Ltd has traded in the range of US$ 12,185 to US$ 15,71 during the past year
What is the PE ratio of Dr Reddys Laboratories Ltd?
The price to earnings ratio of Dr Reddys Laboratories Ltd is 24,88
What is the cash to sales ratio of Dr Reddys Laboratories Ltd?
The cash to sales ratio of Dr Reddys Laboratories Ltd is 3,17
What is the registered address of Dr Reddys Laboratories Ltd?
The registered address for Dr Reddys Laboratories Ltd is 8-2-337, Road No. 3, Hyderabad, 500034
What is the Dr Reddys Laboratories Ltd website address?
The website address for Dr Reddys Laboratories Ltd is www.drreddys.com
Which industry sector does Dr Reddys Laboratories Ltd operate in?
Dr Reddys Laboratories Ltd operates in the Pharmaceuticals sector

RDY Transactions

Plus

Transactions différées

Pour obtenir des transactions en temps réel, améliorez votre compte

Passer à la version en temps réel
Aucune Discussion Trouvée
Ajouter une Discussion

Dernières Valeurs Consultées

Delayed Upgrade Clock